- Home
- VVPR vs VERU Comparison
VVPR vs VERU Comparison
Compare VVPR & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVPR
- VERU
- Stock Information
- Founded
- VVPR 2014
- VERU 1971
- Country
- VVPR United Kingdom
- VERU United States
- Employees
- VVPR N/A
- VERU N/A
- Industry
- VVPR Power Generation
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- VVPR Utilities
- VERU Health Care
- Exchange
- VVPR Nasdaq
- VERU Nasdaq
- Market Cap
- VVPR 40.2M
- VERU 40.6M
- IPO Year
- VVPR 2016
- VERU 1990
- Fundamental
- Price
- VVPR $2.45
- VERU $2.33
- Analyst Decision
- VVPR
- VERU Strong Buy
- Analyst Count
- VVPR 0
- VERU 2
- Target Price
- VVPR N/A
- VERU $25.00
- AVG Volume (30 Days)
- VVPR 572.0K
- VERU 197.4K
- Earning Date
- VVPR 01-01-0001
- VERU 12-15-2025
- Dividend Yield
- VVPR N/A
- VERU N/A
- EPS Growth
- VVPR N/A
- VERU N/A
- EPS
- VVPR N/A
- VERU N/A
- Revenue
- VVPR $61,000.00
- VERU $16,886,419.00
- Revenue This Year
- VVPR N/A
- VERU N/A
- Revenue Next Year
- VVPR N/A
- VERU N/A
- P/E Ratio
- VVPR N/A
- VERU N/A
- Revenue Growth
- VVPR 281.25
- VERU 337.24
- 52 Week Low
- VVPR $0.62
- VERU $2.11
- 52 Week High
- VVPR $8.88
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- VVPR 37.23
- VERU 33.93
- Support Level
- VVPR $2.05
- VERU $2.11
- Resistance Level
- VVPR $3.64
- VERU $2.57
- Average True Range (ATR)
- VVPR 0.35
- VERU 0.19
- MACD
- VVPR -0.03
- VERU -0.00
- Stochastic Oscillator
- VVPR 27.04
- VERU 34.67
About VVPR VivoPower International PLC
Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.